+ All Categories
Home > Business > Wednesday 1 ursula hultkvist bengtsson medicon valley

Wednesday 1 ursula hultkvist bengtsson medicon valley

Date post: 08-May-2015
Category:
Upload: michiel-stoffels
View: 392 times
Download: 4 times
Share this document with a friend
33
Medicon Village For people´s health and well-being Ursula Hultkvist Bengtsson Executive Vice President
Transcript
Page 1: Wednesday 1 ursula hultkvist bengtsson medicon valley

Medicon Village

For people´s health and well-being

Ursula Hultkvist BengtssonExecutive Vice President

Page 2: Wednesday 1 ursula hultkvist bengtsson medicon valley

Medicon Village – Medicon ValleyThe Village in the Valley

Medeon

Ideon

MediconVillage

Page 3: Wednesday 1 ursula hultkvist bengtsson medicon valley

Titel, namn och tidpunkt

Page 4: Wednesday 1 ursula hultkvist bengtsson medicon valley

2 March 2010– AstraZeneca will move to Mölndal – staff meeting –

900 people to lose their jobs

2 March 2010– Allan Larsson appointed chief negotiator and to

develop a Life Science concept by FIRS (Forsknings- och Innovationsrådet i Skåne = Research and Innovation Council Skåne)

14 January 2011– Mats Paulsson´s Foundation announced. 100 milj

SEK donated and surplus reinvested into research and innovation.

10 January 2012 – Medicon Village being launched

From bad to good…

Page 5: Wednesday 1 ursula hultkvist bengtsson medicon valley

AstraZeneca exit from LundAchievements and learnings

Governance: Accountability for managing the change and external stakeholders (regional partners, media etc.) very unclear the first 5 months. Great improvement during autumn 2010 when leadership team was empowered and resources made available.

Success factors•Transformation from global to local•External, pro-active communication plan•Local accountabilities with senior team members; well defined objectives; budget/resource; focus on solutions and transparency•Internal AZ project teams working closely with LCT on well defined projects•LCT culture and behaviours: Silos broken, one for all – all for one; breathe the air in Lund!

Engagement: Critical for keeping up the spirit and finding the strength and commitment to deliver the objectives in a difficult situation.

Success factors•Dedicated local leaders•A variety of events and activities were arranged both by LCT and functions

• Career support activities• Focus on motivation and well-being

•Site sale – an extremely important achievement!

• Handover project (Buildings/instruments, IS/IT, competence)

5Lund LCT | October 2011

Never underestimate peoplesʼ driving force to do a good job. But donʼt take it for granted!

Page 6: Wednesday 1 ursula hultkvist bengtsson medicon valley

Never underestimate peoplesʼ driving

force to do a good job. But donʼt take

it for granted!

AstraZeneca exit from LundAchievements and learnings

Recruitment and relocation: Functional reorganisations in parallel with moving a business with people, projects and equipment is more complicated than one can ever imagine•New organisation in Mölndal not in place to provide pull until late 2010/early 2011•More people may have moved with firmer/faster processRedundancy: Redundancy/early retirement packages; people had to wait too long for information, but perceived as generous when it came•Local HR Center an excellent improvement when in place, but would have been even better if also early retirement was managed locally•Local career support activities outstanding!

Communications: After announcement of the site closure and during a large part of 2010 the general perception was that there was no communication by global R&D.

Initially the unions “provided the lifeline” and local functional leadership provided the stability.

From Q3 2010 and forward a strong improvement was seen in communication when local ownership and resources came in place.

Success factors

•Visible local leadership (by LCT and functions) provided clarity and a sense of security

•Several well-managed communication channels

6Lund LCT | October 2011 R&D | PMO

Page 7: Wednesday 1 ursula hultkvist bengtsson medicon valley

Executive summary

• 85% had moved in August 201180% of staff signed up have their work‐place in 

Mölndal by end of August 2011 and all relocated by end of October 2011 

• 85% had a plan75% of people made redundant have a plan for new opportunities within 6 months

• ready to hand over before December 2011. Steering group decided on January 2012.

Lund site transferred to new owners at the latest by end of December 2011

• Survey among employees > 90 % agreed or strongly agreed

Exiting Lund perceived to be done in a responsible way with respect for employees

•Outstanding (Swedish independent analysis by Mediapilot AB)Maintain corporate reputation

Lund LCT achievements and deliverables

7Lund LCT | October 2011

Objectives Results

Page 8: Wednesday 1 ursula hultkvist bengtsson medicon valley

Swedish Independent media analysis by Mediapilot AB

• ”The conclusion is that AstraZeneca in many ways have succeeded in turning negative news to positive publicity by showing responsibility and understanding of their employees. Even though the news around the site closure are negative per se, there has been a lot of positive outcomes.”

1 March 2010 – 30 September 2011

8Lund LCT | October 2011 R&D | PMO

Page 9: Wednesday 1 ursula hultkvist bengtsson medicon valley

What has happened with the employees Nov 2011?

892 employees in Lund March 2, 2010

9

Moved to Mölndal (23%) (40% of 520 that were asked)

Retired (12,1%)

External – New Company (32,3%)

Business start up (7,7%)

Education(8,2%)

Active job hunters or decided to take a break (16,5%)

More than 80% know their future!

Page 10: Wednesday 1 ursula hultkvist bengtsson medicon valley

Medicon Village

For people´s health and well-being

Page 11: Wednesday 1 ursula hultkvist bengtsson medicon valley

MalmöCopenhagen/

Kastrup

Lund

Öresundsbridge

Ideon

University

Cooperation ahead!

ESS

MAX IV

MediconVillage SUS

Page 12: Wednesday 1 ursula hultkvist bengtsson medicon valley

Medicon Village Research, innovation and business

ESS Head Office 

Conference and restaurant

Appr. 30 life science companies(B2B)

Lund Life Science Incubatorappr. 20 companies

Cancer Centre Region Skåne Biobank

Innovation partners and institutes

Primary Care Skåne

Science Support & labshop

Page 13: Wednesday 1 ursula hultkvist bengtsson medicon valley

Facts & Figures March 2013

• Launched 10th January 2012• Former AstraZeneca site• Laboratories 30 000 m2 • Offices, Conference 50 000 m2

• >600 members• An additional 200 cancer researchers from June 2013

• >75 organizations– 22 product companies– 51 service companies/providers– 2 institutes

13

Page 14: Wednesday 1 ursula hultkvist bengtsson medicon valley

Life ScienceForesight Institute 

Regionalt biobankscentrum

Page 15: Wednesday 1 ursula hultkvist bengtsson medicon valley

Medicon Village members (product and R&D companies)

Cancer Resp./inflam. Other indications Prevention

Material

Diagnostics Treatment Diagnostics Treatment Prevention Diagnostics Care Treatment Other

Chemistry

Medtech

E‐Health/m‐health

Nano‐medicine

Biotech

Pharma

2013 03 10

Page 16: Wednesday 1 ursula hultkvist bengtsson medicon valley

Entire value chain –embracing the whole individual

At Medicon Village we want to create an environment where research, innovation and entrepreneurship work

together to create value for people’s health and wellbeing

Page 17: Wednesday 1 ursula hultkvist bengtsson medicon valley

What makes Medicon Village unique?• A development company owned by

Mats Paulsson´s Foundation for research, innovation and societal development

• Profits reinvested in research and innovation

• Members moving into premises ready to use - complete R&D site

• The entire value chain, from researchers to innovators and businessmen are represented

• Giving small companies the same advantages that can normally only be enjoyed by large companies

TRIPLE HELIX in actionBOARD MEMBERS OF MATS PAULSSON´S FOUNDATION:Allan Larsson, former chairman of Lund UniversityPia Kinhult, First Governor ,Chair of the Regional Executive CommitteeGöran Grosskopf, Mats Paulsson´s FoundationMats Paulsson, Mats Paulsson´s FoundationPer Eriksson, Vice-Chancellor, Lund University

Page 18: Wednesday 1 ursula hultkvist bengtsson medicon valley

Prevention Diagnosis Treatment Care

From basic research  tomature companies

covering the entire valuechain

Body and Mind inseparable

Page 19: Wednesday 1 ursula hultkvist bengtsson medicon valley

Lund University & Medicon VillageCreating one of strongest cancer research units in Europe

Page 20: Wednesday 1 ursula hultkvist bengtsson medicon valley

Mobile Health

Processing Knowledge

1+1=5

Processing start-up incubation

Nanomedicin center

One stop shop:Max IV

ESS Science Village

Scandinavia

Externalization &

Partnerships

Drug Delivery Institute

Move the challenge at Medicon Village

Health Informatics

Medicon Village Clinics

Medicon Village

Foundation

Medicon Skills

Centre

Page 21: Wednesday 1 ursula hultkvist bengtsson medicon valley

Today

Page 22: Wednesday 1 ursula hultkvist bengtsson medicon valley

Possible expansion

Page 23: Wednesday 1 ursula hultkvist bengtsson medicon valley

A world class player within Life Science

Externalization is an important part of Medicon Village’s concept and international partnerships are being worked on, both in the east and over the Atlantics to the west.

Page 24: Wednesday 1 ursula hultkvist bengtsson medicon valley

World class cluster criteria Jones Lang LaSalle (2011)

Situation in Medicon Valley?• Educated workforce• Venture and investment capital• Centers of excellence and innovation• Industry-friendly political structures• Institutions of higher learning• Target oriented economic development incentives• Patent protection• Supporting infrastructure

Page 25: Wednesday 1 ursula hultkvist bengtsson medicon valley

Medicon Village Twin Clusters & Partnerships

• Twinning 2013, 2014, 2015• Partnerships near by• Proposals

Page 26: Wednesday 1 ursula hultkvist bengtsson medicon valley

Twinning Life Science clusters- between similar eco systems

Page 27: Wednesday 1 ursula hultkvist bengtsson medicon valley

Memorandum of Understanding: Wales

The participants will strongly pursue for mutual benefit the potential for collaboration in the field of Life Sciences, technology, innovation, research and development and their commercial exploitation.

The participants will promote the establishment of co-operative relationships between companies, organisations, universities and investors in their respective countries.

The participants will promote business and trade opportunities and provide practical assistance to organisations, universities and other innovative enterprises wishing to collaborate or locate in the other region.

The participants will promote international business development, encouraging innovation and research collaborations and facilitating the identification of partners, collaborators and investors between the regions.

The participants will invite the other region to participate in relevant conferences in the field of Life Sciences.

The participants will seek to maintain regular contact to facilitate consultations on the exchanges and cooperation as well as matters of common concern.

The participants will also seek to involve other parties in the implementation of this memorandum.

Page 28: Wednesday 1 ursula hultkvist bengtsson medicon valley

Memorandum of Understanding: Wales Life Science Cluster and Medicon VillageLaunch 19 March 2013

Growthvia 

Twinning

Growthvia 

TwinningConnectingConnecting

PromotingPromoting

SupportingSupporting

PartneringPartnering

EnjoyingEnjoying

ExcellingExcelling

Co‐operatingCo‐operating

CollaboratingCollaboratingConsultingConsulting

DevelopingDeveloping

EncouragingEncouraging

FacilitatingFacilitating

ParticipatingParticipating

ImplementingImplementing

InvolvingInvolving

ExchangingExchanging

AssistingAssisting

Page 29: Wednesday 1 ursula hultkvist bengtsson medicon valley

Twin Clusters (1) –between similar eco systems• Areas of interest:• Innovation - Process and Product• Cancer• Diabetes• Neuroscience• Translational research• Philanthropy and Venture Capital

• Cooperation/invest perspective: • Promote the establishment of co-operative relationships between companies

and organizations in our respective countries.• Promote international business development, encouraging innovation and research collaborations

between the two regions.• Facilitate the identification of partners, collaborators and (international) investors to provide

international business development.• Explore opportunities in respective innovation systems

Page 30: Wednesday 1 ursula hultkvist bengtsson medicon valley

Twin Clusters (2)

• Company perspective: • Co-incubation of start-ups• Port of entry to respective country for growth of a company• Promote business opportunities and access to trade opportunities in respective countries.

• Research perspective:• Facilitate research collaboration regarding e.g. ESS and respective university – bridging between

teams and individuals• Bio banks • Stimulate collaboration cross-institutions

– Including hospitals and healthcare– Identifying partners

Page 31: Wednesday 1 ursula hultkvist bengtsson medicon valley

Thank you

and

Welcome

back to

Medicon [email protected]

+46 709 131236

Page 32: Wednesday 1 ursula hultkvist bengtsson medicon valley

Lund Life Science Incubator is a business incubator which helps entrepreneurs and small companies within the field of Life Science to develop and commercialize their ideas

Lund Life Science Incubator

Structural Biology and Structure-Based Drug Design Outsourcing

A research and development company dedicated to find new ways to promote better health for patients with autoimmune disorders

Provides life science and drug development consultancy with an emphasis on biology and translational science.

Developes BioBarrier™, an effective and user friendly post-surgical adhesion barrier spray.

The incubator hosts both product companies and service companies, working in different fields and in different stages of development. This breadth provides an dynamic environment and knowledge exchange.

Page 33: Wednesday 1 ursula hultkvist bengtsson medicon valley

The European Spallation Source

The European Spallation Source (ESS) is a multi-disciplinary research centre based on the world’s most powerful neutron source. It is a European project with, at present, 17 Partner Countries, with Sweden and Denmark as host nations.

The facility will be around 30 times brighter than today's leading facilities, enabling new opportunities for researchers in the fields of life sciences, energy, environmental technology, cultural heritage and fundamental physics.

The European Spallation Source is one of the largest science and technology infrastructure projects being built today.


Recommended